TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Hans Lennernäs Biomedical AB
Closing information (x1000 EUR)
| Closing information | 2023/06 | 2022/06 | 2021/06 |
| Turnover |
73
|
48 | |
| Financial expenses |
40
|
0 | |
| Earnings before taxes |
6
|
-9 | |
| EBITDA |
45
|
-11 | |
| Total assets |
1,418
|
1,508 | |
| Current assets |
88
|
69 | |
| Current liabilities |
25
|
16 | |
| Equity capital |
1,381
|
1,479 | |
| - share capital |
9
|
10 | |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Solvency |
97.4%
|
98.1% | |
| Turnover per employee |
73
|
48 | |
| Profit as a percentage of turnover |
8.2%
|
-18.8% | |
| Return on assets (ROA) |
3.2%
|
-0.6% | |
| Current ratio |
352.0%
|
431.2% | |
| Return on equity (ROE) |
0.4%
|
-0.6% | |
| Change turnover |
28
|
-12 | |
| Change turnover % |
62%
|
61%
|
-20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/06 | 2022/06 | 2021/06 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.